scholarly journals Anti-EGFR monoclonal antibodies increase the risk of Pulmonary Embolism in Cancer Patients. a systematic review and meta-analysis

2015 ◽  
Vol 37 (8) ◽  
pp. e83
Author(s):  
M. Miroddi ◽  
C. Sterrantino ◽  
V. Conti ◽  
A. Rollo ◽  
G. Calapai
Keyword(s):  
Systematic Review ◽  
Pulmonary Embolism ◽  
Monoclonal Antibodies ◽  
Cancer Patients ◽  
Meta Analysis

Anti-EGFR monoclonal antibodies and risk of severe Haematological adverse events in Cancer Patients: a systematic review and meta-analysis

2015 ◽  
Vol 37 (8) ◽  
pp. e83
Author(s):  
M. Miroddi ◽  
P. Pellegrino ◽  
C. Sterrantino ◽  
L. Caridi ◽  
A. Rollo ◽  
...  
Keyword(s):  
Systematic Review ◽  
Monoclonal Antibodies ◽  
Adverse Events ◽  
Cancer Patients ◽  
Meta Analysis

scholarly journals Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab)

2016 ◽  
Vol 139 (10) ◽  
pp. 2370-2380 ◽  
Author(s):  
Marco Miroddi ◽  
Carmelo Sterrantino ◽  
Mark Simmonds ◽  
Luigi Caridi ◽  
Gioacchino Calapai ◽  
...  
Keyword(s):  
Systematic Review ◽  
Monoclonal Antibodies ◽  
Cancer Patients ◽  
Meta Analysis ◽  
Life Threatening

C0546: Unsuspected Pulmonary Embolism in Cancer Patients: A Systematic Review and Meta-Analysis

2014 ◽  
Vol 133 ◽  
pp. S106
Author(s):  
M. Donadini ◽  
F. Dentali ◽  
A. Squizzato ◽  
L. Guasti ◽  
W. Ageno
Keyword(s):  
Systematic Review ◽  
Pulmonary Embolism ◽  
Cancer Patients ◽  
Meta Analysis
Sign in / Sign up

Export Citation Format

Share Document